SCHEMBL4973271

SCHEMBL4973271

CN(CC(N)CC12CCC(CC1)CC2)C(=O)O

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1864431 0.72 CTSS (0.31)
SCHEMBL22117545 0.71 GRM1 (0.52)
SCHEMBL22117543 0.71 GRM1 (0.52)
SCHEMBL3588546 0.69 ANPEP (0.40) DPP4
SCHEMBL3588545 0.69 ANPEP (0.40) DPP4
SCHEMBL3614943 0.69 ANPEP (0.40) DPP4
SCHEMBL5509805 0.68 USP2 (0.34) DPP4
SCHEMBL27689705 0.68 USP2 (0.34) DPP4
SCHEMBL3607510 0.68 GPR88 (0.41) DPP4
SCHEMBL3338710 0.68 GPR88 (0.41) DPP4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1966139-A1 ASPARTIC PROTEASE INHIBITORS Vitae Pharmaceuticals, Inc. (US) 2008-09-10 EP disclosed
WO-2007070201-A1 ASPARTIC PROTEASE INHIBITORS VITAE PHARMACEUTICALS, INC. (US) 2007-06-21 WO disclosed